For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
COVID-19: Contact tracing locations of interest - 19 August - am
COVID-19: Contact tracing locations of interest - 19 August - am

Locations of interest for people who may be contacts of COVID-19 cases in the community. Contacts who attended one of the locations in New Zealand during the relevant times are asked to follow the directions below.
What to do if you have been at a location listed in the attached pdf
If you have been at any of these locations of interest during the relevant time, please self-isolate and call Healthline on 0800 358 5453 for advice on what to do to help prevent the spread of COVID-19. This is free and you can call any time – it is open all day every day.
A section 70 order enables an authorised Medical Officer of Health to require those who have visited a location of interest to meet public health requirements. Read the current section 70 for New Zealand.
If you are a household member of a person who has been at a location of interest, please isolate at home until the person who was at the location receives a negative test (you do not need to be tested unless you are asked to be). Read the Section 70 notice.